Micromedic Announces Receipt of Regulatory Approval to Commercialize CellDetect® Bladder Cancer Monitoring Kit in Israel

Micromedic Announces Receipt of Regulatory Approval to Commercialize CellDetect® Bladder Cancer Monitoring Kit in Israel

 
Micromedic announces receipt of regulatory approval to commercialize its CellDetect® bladder cancer monitoring kit in Israel (AMAR registration) and signing of a distributor agreement with Gamidor Diagnostics for the marketing and sale of the product in Israel.


More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi